United States v. Hsu

CourtCourt of Appeals for the Third Circuit
DecidedAugust 26, 1998
Docket97-1965
StatusUnknown

This text of United States v. Hsu (United States v. Hsu) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Hsu, (3d Cir. 1998).

Opinion

Opinions of the United 1998 Decisions States Court of Appeals for the Third Circuit

8-26-1998

United States v. Hsu Precedential or Non-Precedential:

Docket 97-1965

Follow this and additional works at: http://digitalcommons.law.villanova.edu/thirdcircuit_1998

Recommended Citation "United States v. Hsu" (1998). 1998 Decisions. Paper 205. http://digitalcommons.law.villanova.edu/thirdcircuit_1998/205

This decision is brought to you for free and open access by the Opinions of the United States Court of Appeals for the Third Circuit at Villanova University School of Law Digital Repository. It has been accepted for inclusion in 1998 Decisions by an authorized administrator of Villanova University School of Law Digital Repository. For more information, please contact Benjamin.Carlson@law.villanova.edu. Filed August 26, 1998

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

No. 97-1965

UNITED STATES OF AMERICA

v.

KAI-LO HSU, a/k/a JAMES HSU

CHESTER S. HO

United States of America, Appellant

ON APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA (D.C. Criminal Nos. 97-cr-323-1 and 97-cr-323-2)

Argued: June 10, 1998

Before: STAPLETON, COWEN, and RENDELL, Circuit Judges

(Opinion Filed: August 26, 1998) Michael R. Stiles Walter S. Batty, Jr. Richard W. Goldberg (ARGUED) Louis D. Lappen Office of the United States Attorney 615 Chestnut Street, Suite 1250 Philadelphia, PA 19106 Attorneys for Appellant

William E. McDaniels (ARGUED) Paul Mogin Williams & Connolly 725 Twelfth Street, N.W. Washington, DC 20005

Thomas H. Suddath, Jr. Montgomery, McCracken, Walker & Rhoads, LLP 123 South Broad Street Philadelphia, PA 19109 Attorneys for Appellee, Chester S. Ho

Norman E. Greenspan Ian M. Comisky Blank Rome Comisky & McCauley LLP One Logan Square Philadelphia, PA 19103 Attorneys for Appellee, Kai-Lo Hsu

OPINION OF THE COURT

RENDELL, Circuit Judge:

In this appeal we explore for the first time the relationship between the confidentiality provisions of the newly-enacted Economic Espionage Act of 1996, 18 U.S.C. S 1831, et seq., and principles of criminal law regarding discovery and disclosure of material evidence. The district court ordered the government to disclose alleged corporate trade secrets based upon a theory that we find does not

2 apply. It also held that the defense of legal impossibility does not pertain to the attempt and conspiracy crimes with which the defendants are charged. We will affirm the court's holding regarding the applicability of the defense of legal impossibility, but will reverse its discovery order and remand for a review of other asserted defenses to the crimes in the indictment.

I. FACTUAL AND PROCEDURAL BACKGROUND

A. The Government's Sting Operation

On July 10, 1997, a federal grand jury indicted Kai-Lo Hsu, Chester S. Ho, and Jessica Chou (collectively,"the defendants") for their involvement in an alleged conspiracy to steal corporate trade secrets from Bristol-Myers Squibb. The indictment alleges that the defendants sought to obtain the processes, methods, and formulas for manufacturing Taxol, an anti-cancer drug produced by Bristol-Myers and regarded by the company as a highly valuable trade secret.1

According to the indictment, the defendants' conspiracy began on June 7, 1995, when Chou, the Manager of Business Development for Yuen Foong Paper Company in Taiwan ("YFP"), requested information about Taxol from John Hartmann, an undercover FBI agent whom Chou mistakenly believed to be a technological information broker in the United States. From August 28, 1995, until January 12, 1996, Chou allegedly contacted Hartmann repeatedly to obtain information about Taxol manufacturing techniques and distribution. These contacts led to a meeting in Los Angeles on February 27, 1996, between Hartmann and Hsu, the Technical Director for YFP's operations. Hsu purportedly told Hartmann at that meeting that YFP wanted to diversify into biotechnology and to _________________________________________________________________

1. The factual summary that follows is based entirely on the as yet unproven allegations in the July 1997 indictment. Because this is an interlocutory appeal, the record is not complete, discovery has not concluded, and no determination of the facts has yet occurred. Therefore, we offer these facts as averred to provide a context for the issues on appeal, without vouching for the truth of any of the facts we recite.

3 introduce technology from advanced countries into Taiwan. When Hartmann responded that Bristol-Myers would be unlikely to share its secret technology with YFP, Hsu allegedly responded, "We'll get [it] another way," and told Hartmann to pursue paying Bristol-Myers employees for the confidential Taxol formulas.

The indictment asserts that Hsu and Chou then "communicated many times" with Hartmann over the next fourteen months to discuss the transfer of Taxol technology and to negotiate a specific price for the acquisition of Bristol-Myers's trade secrets. In response, Hartmann told the defendants that a corrupt Bristol-Myers scientist would be willing to sell Taxol information to YFP. The"corrupt" scientist was actually a Bristol-Myers employee cooperating with the FBI. Intrigued by such a prospect, Chou allegedly sent an e-mail to Hartmann on March 13, 1997, outlining the "core technology" that YFP would need to complete a deal, including:

"1. The design and assembly of bioreactor with an agreed scale 2. Light requirement 3. Media requirement for growth and production 4. Operating mode for the process, such as batch or continuous 5. Yield, such as cell density, titers, taxane constitution 6. Duration of culture to reach the maximal yield 7. Scientific names of yew species which are applicable to the bioreactor. 8. Cell lines excluded!!!"

Chou also allegedly told Hartmann that she would offer $400,000 in cash, stock, and royalties to the Bristol-Myers scientist in exchange for his disclosure of the Taxol secrets. In addition, Chou and Hsu purportedly began making arrangements for a 1997 meeting between the parties, the purpose of which was for YFP to establish the authenticity of the "corrupt" scientist and to determine whether Hartmann really could produce the Taxol trade secrets that Chou and Hsu had requested.

Hartmann agreed to a meeting, and on June 14, 1997, he and the Bristol-Myers scientist met with three

4 representatives from YFP, including Hsu, Ho, and another unidentified scientist, at the Four Seasons Hotel in Philadelphia. Ho was a professor of biotechnology and the Director of the Biotechnology Innovation Center at the National Chiao Tung University in Taiwan, and he had apparently been asked to evaluate the Taxol technology at the meeting as a favor to YFP.

The indictment alleges that the bulk of the June 14 meeting consisted of detailed discussions regarding the manufacturing processes for Taxol. The Bristol-Myers scientist explained the background and history of Taxol production, and displayed copies of Bristol-Myers documents outlining specific technological processes and scientific data pertaining to the manufacture of the drug. According to the indictment, these documents contained trade secrets and were "clearly marked with Bristol-Myers identification as well as the block stamped word `CONFIDENTIAL.' " Hsu, Ho, and the other YFP employee reviewed the documents during the meeting and purportedly asked the Bristol-Myers scientist "numerous" questions regarding specific areas of Taxol technology. Finally, after Hartmann and the Bristol-Myers scientist left the room, the FBI rushed in and arrested Hsu and Ho at the hotel.2

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Morissette v. United States
342 U.S. 246 (Supreme Court, 1952)
United States v. Feola
420 U.S. 671 (Supreme Court, 1975)
United States v. Thomas Arthur Darnell
545 F.2d 595 (Eighth Circuit, 1976)
United States v. Nelson E. "Buck" Sanford
547 F.2d 1085 (Ninth Circuit, 1976)
United States v. Abel v. Quijada
588 F.2d 1253 (Ninth Circuit, 1979)
United States v. William Bocra
623 F.2d 281 (Third Circuit, 1980)
United States v. Everett, George
700 F.2d 900 (Third Circuit, 1983)
United States v. Wallace G. Wallington
889 F.2d 573 (Fifth Circuit, 1989)
United States v. Kikumura, Yu
918 F.2d 1084 (Third Circuit, 1990)
United States v. John M. Brown
925 F.2d 1301 (Tenth Circuit, 1991)
United States v. Hector Cruz-Jiminez
977 F.2d 95 (Third Circuit, 1992)
Harris v. City of Philadelphia
35 F.3d 840 (Third Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Hsu, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-hsu-ca3-1998.